GMAB:NASDAQ
Genmab A/S - ADR
$51.37
arrow_downward
-0.72%(-0.37) 1D
$51.37
0.00% (0.00)
bedtimeAfter hours
Closed: Nov 13, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GMAB...
Open
$51.22
High
$51.62
Low
$50.68
Mkt. cap
32.45B
Avg. vol.
5.97M
Volume
3.73M
P/E ratio
43.75
52-wk high
$59.97
52-wk low
$23.62
EPS
$1.17
Beta
0.73
Shares outstanding
624.06M
No. of employees
3K
Open
$51.22
High
$51.62
Low
$50.68
Mkt. cap
32.45B
Avg. vol.
5.97M
Volume
3.73M
P/E ratio
43.75
52-wk high
$59.97
52-wk low
$23.62
EPS
$1.17
Beta
0.73
Shares outstanding
624.06M
No. of employees
3K
News stories
From web sources and news partners
GuruFocus
·
15 hours ago
GMAB Maintained by Morgan Stanley -- Price Target Lowered to $56
Yahoo Finance
·
1 day ago
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
Quantisnow
·
1 day ago
GMAB: CEO Jan van de Winkel sold 22,000 Genmab shares
Yahoo Finance
·
4 days ago
GMAB 6-K & SEC Filings
Profile
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, Genmab K.K. in Tokyo, Japan, Genmab Germany GmbH in München, Germany and Genmab Co., Ltd. in Suzhou, China. Genmab is listed on the Copenhagen Stock Exchange in Denmark, with American depositary receipts traded on the NASDAQ in the US. Wikipedia
About Genmab A/S - ADR
CEOJan G. J. van de Winkel
Employees3.24K
Founded1999
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitegenmab.com